Uncategorized

SoapBoxSample’s COVID-19 Antibody Research Featured in the Journal of the American Medical Association

Lab tech looking at test

SoapBoxSample Assisted with the Ongoing COVID-19 Antibody Research

Groundbreaking COVID-19 antibody research from SoapBoxSample was featured in the Journal of the American Medical Association, published May 18, 2020. The Journal of the American Medical Association is a peer-reviewed medical journal published 48 times a year by the American Medical Association. It publishes original research, reviews, and editorials covering all aspects of biomedicine. The study reviewed in this article was the pilot wave of a research initiative conducted in partnership with the University of Southern California and the LA County Department of Public Health. SoapBoxSample assisted with the ongoing research engagement to test Angelenos for COVID-19 antibodies in their blood. By launching this critical study, researchers and public officials hoped to get closer to answering the question of when society could “get back to normal.” SoapBoxSample designed the research instrument and recruited 865 Angelenos for the initial pilot test. Subsequently, 1015 additional Los Angeles County residents were recruited for wave 2. SoapBoxSample’s expertise in reaching diverse multicultural audiences, and deep roots in the LA community allowed them to efficiently contact and recruit participants. Antibody testing is ongoing in LA County and SoapBoxSample continues to provide data for this important research initiative.

Article Excerpt:

“Inadequate knowledge about the extent of the coronavirus disease 2019 (COVID-19) epidemic challenges public health response and planning. Most reports of confirmed cases rely on polymerase chain reaction–based testing of symptomatic patients. These estimates of confirmed cases miss individuals who have recovered from infection, with mild or no symptoms, and individuals with symptoms who have not been tested due to limited availability of tests.

We conducted serologic tests in a community sample to estimate cumulative incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, as serologic tests identify both active and past infections.”

Read the Full Article